International Time Trends and Differences in Topical Actinic Keratosis Therapy Utilization
JAAD International(2024)
摘要
Background
Actinic Keratoses (AK) are pre-cancerous lesions that can lead to Squamous Cell Carcinoma (SCC). International differences in the utilization of topical medications to treat AK are not well described.
Objectives
To describe international differences in topical AK medication utilization, including associations of countries’ economic status with AK medication utilization.
Methods
We used IQVIA MIDAS® pharmaceutical sales data for 65 countries (42 high-income, 24 middle-income) from April 2011 to December 2021. We calculated each country’s quarterly utilization of medications in grams per 1,000 population. We used univariable linear regression to assess the association between country economic status and AK medication utilization.
Results
High-income countries used 15.37 more grams per 1,000 population of 5-fluorouracil (95% CI: 9.68, 21.05), 4.64 more grams per 1,000 population of imiquimod (95% CI: 3.45, 5.83), and 0.32 more grams per 1,000 population of ingenol mebutate (95% CI: 0.05, 0.60).
Limitations
Missing medication utilization data for some countries.
Conclusion
High-income countries use more topical AK therapies than middle-income countries.
更多查看译文
关键词
Squamous cell carcinoma,Medication utilization,actinic keratosis,global dermatology,international medication utilization,SCC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要